Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multimodal Imaging and En Face OCT Detection of Calcified Drusen in Eyes with Age-Related Macular Degeneration. | Ophthalmol Sci | 2022 | 35935092 | PubTator, text mining | PubMed |
| Complexity and clinical significance of drug-drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT). | Support Care Cancer | 2022 | 35932318 | PubTator, text mining | PubMed |
| Phenotypic Expression of CFH Rare Variants in Age-Related Macular Degeneration Patients in the Coimbra Eye Study. | Invest Ophthalmol Vis Sci | 2022 | 35925583 | PubTator, text mining | PubMed |
A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration. | Indian J Ophthalmol | 2022 | 35918962 | PubTator, text mining | PubMed |
| Morphological characterization of subretinal hyper-reflective material in posterior uveitis using swept-source optical coherence tomography and optical coherence tomography angiography. | Indian J Ophthalmol | 2022 | 35918956 | PubTator, text mining | PubMed |
| Correlation of pattern of visual field loss by perimetry and anterior chamber angle parameters by anterior segment optical coherence tomography in primary angle-closure glaucoma. | Indian J Ophthalmol | 2022 | 35918939 | PubTator, text mining | PubMed |
| Highly Invasive Fluorescent/Bioluminescent Patient-Derived Orthotopic Model of Glioblastoma in Mice. | Front Oncol | 2022 | 35912166 | PubTator, text mining | PubMed |
| Argininosuccinate synthase 1, arginine deprivation therapy and cancer management. | Front Pharmacol | 2022 | 35910381 | PubTator, text mining | PubMed |
| Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats. | Exp Neurol | 2022 | 35905840 | PubTator, text mining | PubMed |
| Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells. | Cell Cycle | 2022 | 35899934 | PubTator, text mining | PubMed |
| Genetic Analysis of HPIV3 That Emerged during the SARS-CoV-2 Pandemic in Gwangju, South Korea. | Viruses | 2022 | 35891425 | PubTator, text mining | PubMed |
| Transcriptional and Translational Dynamics of Zika and Dengue Virus Infection. | Viruses | 2022 | 35891396 | PubTator, text mining | PubMed |
| The Role of Latency-Associated Transcripts in the Latent Infection of Pseudorabies Virus. | Viruses | 2022 | 35891360 | PubTator, text mining | PubMed |
| Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. | Pharmaceutics | 2022 | 35890396 | PubTator, text mining | PubMed |
| Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. | Pharmaceuticals (Basel) | 2022 | 35890085 | PubTator, text mining | PubMed |
| Casitas B-lineage lymphoma Gene Mutation Ocular Phenotype. | Int J Mol Sci | 2022 | 35887217 | PubTator, text mining | PubMed |
| Predicting Visual Field Progression by Optical Coherence Tomography Angiography and Pattern Electroretinography in Glaucoma. | J Glaucoma | 2022 | 35882039 | PubTator, text mining | PubMed |
| Depicting Developing Trend and Core Knowledge of Primary Open-Angle Glaucoma: A Bibliometric and Visualized Analysis. | Front Med (Lausanne) | 2022 | 35865166 | PubTator, text mining | PubMed |
| Pigmentary lesions in eyes with rhegmatogenous retinal detachment with flap tears: a retrospective observational study. | Sci Rep | 2022 | 35864144 | PubTator, text mining | PubMed |
| Barotrauma and its complications in COVID-19 patients: a retrospective study at tertiary care hospital of Eastern India. | Bull Natl Res Cent | 2022 | 35854795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=46